Abstract
The last decade has witnessed an explosion in efforts to discover and validate lupus biomarkers. The currently steep trajectory of this progress is unprecedented. However, advances in the lupus biomarker field remain fewer and slower than physicians, patients, and pharmaceutical companies have hoped for. This chapter will review the challenges confronted by physicians and scientists in pursuit of lupus biomarkers and will present our experience on this path and specific efforts to surmount some of the obstacles in this endeavor. A comprehensive review of the current landscape in lupus biomarker research has recently been published elsewhere (Ahearn et al. Transl Res 159:326–342, 2012; Liu et al. Ther Adv Musculoskelet Dis 5:210–233, 2013; Liu and Ahearn Best Pract Res Clin Rheumatol 23:507–523, 2009; Liu et al. Curr Opin Rheumatol 17:543–549, 2005).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahearn JM, Liu CC, Kao AH, Manzi S (2012) Biomarkers for systemic lupus erythematosus. Transl Res 159:326–342
Liu CC, Kao AH, Manzi S, Ahearn J (2013) Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis 5:210–233
Liu CC, Ahearn JM (2009) The search for lupus biomarkers. Best Pract Res Clin Rheumatol 23:507–523
Liu CC, Manzi S, Ahearn JM (2005) Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol 17:543–549
Narain S, Richards HB, Satoh M, Sarmiento M, Davidson R, Shuster J (2004) Diagnostic accuracy for lupus and other autoimmune diseases in the community setting. Arch Intern Med 164:2435–2441
Fritzler M (2011) The antinuclear antibody test: last or lasting gasp? Arthritis Rheum 63:19–22
Liu CC, Manzi S, Kao AH, Navratil JS, Ahearn JM (2010) Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside. Rheum Dis Clin North Am 36:161–172
Calano SJ, Shih PB, Liu CC, Kao AH, Navratil JS, Manzi S et al (2006) Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers. Adv Exp Med Biol 586:381–390
Liu CC, Danchenko N, Navratil JS, Nilson SE, Manzi S, Ahearn JM (2005) Mining the complement system for lupus biomarkers. Clin Appl Immunol Rev 5:185–206
Liu CC, Manzi S, Danchenko N, Ahearn JM (2004) New advances in measurement of complement activation: lessons of systemic lupus erythematosus. Curr Rheumatol Rep 6:375–381
Liu CC, Ahearn JM, Manzi S (2004) Complement as a source of biomarkers in systemic lupus erythematosus: past, present and future. Curr Rheumatol Rep 6:85–88
Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE et al (2004) Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 50:3596–3604
Kao AH, Navratil JS, Ruffing MJ, Liu CC, Hawkins D, McKinnon KM et al (2010) Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. Arthritis Rheum 62:837–844
Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM (2005) Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum 52:3087–3099
Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ et al (2006) Platelet C4d is highly specific for systemic lupus erythematosis. Arthritis Rheum 54:670–674
Kao AH, McBurney CA, Sattar A, Lertratanakul A, Wilson NL, Rutman S et al (2013) Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus. Transl Stroke Res (in press)
Liu CC, Kao AH, Hawkins DM, Manzi S, Sattar A, Wilson N (2009) Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus. Clin Transl Sci 2:300–308
Yang DH, Chang DM, Lai JH, Lin FH, Chen CH (2009) Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus. Rheumatology 48:1083–1087
Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA et al (2012) Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum 64:4040–4047
Ghiran IC, Zeidel ML, Shevkoplyas SS, Burns JM, Tsokos GC, Kyttaris VC (2011) SLE serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production. Arthritis Rheum 63:503–512
Borschukova O, Paz Z, Ghiran IC, Liu CC, Kao AH, Manzi S et al (2012) Complement fragment C3d is colocalized within lipid rafts of T cells and promotes cytokine production. Lupus 21:1294–1304
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Ahearn, J.M., Manzi, S., Liu, CC. (2014). The Lupus Biomarker Odyssey: One Experience. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0326-9_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0325-2
Online ISBN: 978-1-4939-0326-9
eBook Packages: Springer Protocols